Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Antigen-specific suppression of inflammatory arthritis using liposomes.

Capini C, Jaturanpinyo M, Chang HI, Mutalik S, McNally A, Street S, Steptoe R, O'Sullivan B, Davies N, Thomas R.

J Immunol. 2009 Mar 15;182(6):3556-65. doi: 10.4049/jimmunol.0802972.

2.

Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen.

Setoguchi K, Misaki Y, Araki Y, Fujio K, Kawahata K, Kitamura T, Yamamoto K.

J Immunol. 2000 Nov 15;165(10):5980-6.

3.

Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB.

Martin E, Capini C, Duggan E, Lutzky VP, Stumbles P, Pettit AR, O'Sullivan B, Thomas R.

Arthritis Rheum. 2007 Jul;56(7):2255-66.

4.

The beta 2-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity.

Cobelens PM, Kavelaars A, Vroon A, Ringeling M, van der Zee R, van Eden W, Heijnen CJ.

J Immunol. 2002 Nov 1;169(9):5028-35.

5.

Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo.

Hoffmann PR, Kench JA, Vondracek A, Kruk E, Daleke DL, Jordan M, Marrack P, Henson PM, Fadok VA.

J Immunol. 2005 Feb 1;174(3):1393-404.

6.

IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine.

Nakagome K, Okunishi K, Imamura M, Harada H, Matsumoto T, Tanaka R, Miyazaki J, Yamamoto K, Dohi M.

J Immunol. 2009 Jul 1;183(1):209-20. doi: 10.4049/jimmunol.0802712.

7.

Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.

Takeda K, Dow SW, Miyahara N, Kodama T, Koya T, Taube C, Joetham A, Park JW, Dakhama A, Kedl RM, Gelfand EW.

J Immunol. 2009 Jul 1;183(1):181-90. doi: 10.4049/jimmunol.0803967.

8.

A novel anti-inflammatory role for simvastatin in inflammatory arthritis.

Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H, Madhok R, Campbell C, Gracie JA, Liew FY, McInnes IB.

J Immunol. 2003 Feb 1;170(3):1524-30.

9.

Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.

Andreakos E, Rauchhaus U, Stavropoulos A, Endert G, Wendisch V, Benahmed AS, Giaglis S, Karras J, Lee S, Gaus H, Bennett CF, Williams RO, Sideras P, Panzner S.

Arthritis Rheum. 2009 Apr;60(4):994-1005. doi: 10.1002/art.24434.

10.

Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein.

Ogata A, Yamashita T, Koyama Y, Sakai M, Nishi S.

Biochem Biophys Res Commun. 1995 Aug 4;213(1):362-6.

PMID:
7543754
11.

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.

González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.

Arthritis Rheum. 2009 Apr;60(4):1006-19. doi: 10.1002/art.24405.

12.
13.
14.

Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.

Riedl P, Wieland A, Lamberth K, Buus S, Lemonnier F, Reifenberg K, Reimann J, Schirmbeck R.

J Immunol. 2009 Jul 1;183(1):370-80. doi: 10.4049/jimmunol.0900505.

15.

Antigen specificity is not required for modulation of lung allergic responses by naturally occurring regulatory T cells.

Joetham A, Takeda K, Okamoto M, Taube C, Matsuda H, Dakhama A, Gelfand EW.

J Immunol. 2009 Aug 1;183(3):1821-7. doi: 10.4049/jimmunol.0900303. Epub 2009 Jul 10.

16.

Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines.

Ulmansky R, Turjeman K, Baru M, Katzavian G, Harel M, Sigal A, Naparstek Y, Barenholz Y.

J Control Release. 2012 Jun 10;160(2):299-305. doi: 10.1016/j.jconrel.2011.12.024. Epub 2011 Dec 28.

PMID:
22226777
17.

Co-delivery of antigen and a lipophilic anti-inflammatory drug to cells via a tailorable nanocarrier emulsion.

Chuan YP, Zeng BY, O'Sullivan B, Thomas R, Middelberg AP.

J Colloid Interface Sci. 2012 Feb 15;368(1):616-24. doi: 10.1016/j.jcis.2011.11.014. Epub 2011 Nov 22.

PMID:
22153851
18.

AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.

Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H, Kielland A, Vosters O, Vanderheyde N, Schiavetti F, Larocque D, Van Mechelen M, Garçon N.

J Immunol. 2009 Nov 15;183(10):6186-97. doi: 10.4049/jimmunol.0901474. Epub 2009 Oct 28.

19.

Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthritis.

Caggiano TJ, Brazzale A, Ho DM, Kraml CM, Trybulski E, Chadwick CC, Chippari S, Borges-Marcucci L, Eckert A, Keith JC, Kenney T, Harnish DC.

J Med Chem. 2007 Nov 1;50(22):5245-8. Epub 2007 Sep 29.

PMID:
17902637
20.

Murine antigen-induced arthritis.

van den Berg WB, Joosten LA, van Lent PL.

Methods Mol Med. 2007;136:243-53.

PMID:
17983153

Supplemental Content

Support Center